Skip to main content
Erschienen in:

27.01.2022 | Original Article

CircCHMP5 Contributes to Ox-LDL-induced Endothelial Cell Injury Through the Regulation of MiR-532-5p/ROCK2 axis

verfasst von: Xia Li, Xiaoli Kang, Yali Di, Shuxian Sun, Liming Yang, Bin Wang, Zheng Ji

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Aberrant expression of circular RNA (circRNA) has been demonstrated to be related to atherosclerosis (AS) formation. However, the mechanism of circCHMP5 (also known as hsa_circ_0003575) in AS formation remains unclear.

Methods

Oxidized low-density lipoprotein (ox-LDL) was used to treat human umbilical vein endothelial cells (HUVECs) to construct a cell injury model. The expression level of circCHMP5, miR-532-5p, and Rho-associated protein kinase 2 (ROCK2) was measured using quantitative real-time PCR. Cell cycle, apoptosis, proliferation, and angiogenesis were determined by flow cytometry, 5-ethynyl-2′-deoxyuridine (EdU) assay, and tube formation assay. In addition, the protein expression of apoptosis markers, inflammation factors, and ROCK2 was detected by western blot analysis. The interaction between miR-532-5p and circCHMP5 or ROCK2 was assessed by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay.

Results

Our results indicated that circCHMP5 was overexpressed in ox-LDL-induced HUVECs. CircCHMP5 knockdown promoted cell cycle, proliferation, and angiogenesis while inhibiting apoptosis and inflammation in ox-LDL-induced HUVECs. MiR-532-5p could be sponged by circCHMP5, and its inhibitor reversed the negative regulation of si-circCHMP5 on ox-LDL-induced HUVECs injury. ROCK2, a target of miR-532-5p, reversed the inhibition effect of miR-532-5p on ox-LDL-induced HUVECs injury. Furthermore, we confirmed that circCHMP5 upregulated ROCK2 by sponging miR-532-5p.

Conclusion

To sum up, our data showed that circCHMP5 regulated the miR-532-5p/ROCK2 axis to accelerate ox-LDL-induced HUVECs injury, confirming that circCHMP5 might be a potential target for AS treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535–46.CrossRefPubMed Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535–46.CrossRefPubMed
4.
Zurück zum Zitat Kattoor AJ, Kanuri SH, Mehta JL. Role of ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26(9):1693–700.CrossRefPubMed Kattoor AJ, Kanuri SH, Mehta JL. Role of ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem. 2019;26(9):1693–700.CrossRefPubMed
5.
Zurück zum Zitat Hartley A, Haskard D, Khamis R. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy<sup/>. Trends Cardiovasc Med. 2019;29(1):22–6.CrossRefPubMed Hartley A, Haskard D, Khamis R. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis - novel insights and future directions in diagnosis and therapy<sup/>. Trends Cardiovasc Med. 2019;29(1):22–6.CrossRefPubMed
6.
Zurück zum Zitat Bian W, Jing X, Yang Z, Shi Z, Chen R, Xu A, et al. Downregulation of LncRNA NORAD promotes ox-LDL-induced vascular endothelial cell injury and atherosclerosis. Aging (Albany NY). 2020;12(7):6385–400.CrossRefPubMed Bian W, Jing X, Yang Z, Shi Z, Chen R, Xu A, et al. Downregulation of LncRNA NORAD promotes ox-LDL-induced vascular endothelial cell injury and atherosclerosis. Aging (Albany NY). 2020;12(7):6385–400.CrossRefPubMed
7.
Zurück zum Zitat Zhang Y, Wang L, Xu J, Kong X, Zou L. Up-regulated miR-106b inhibits ox-LDL-induced endothelial cell apoptosis in atherosclerosis. Braz J Med Biol Res. 2020;53(3):e8960.CrossRefPubMedPubMedCentral Zhang Y, Wang L, Xu J, Kong X, Zou L. Up-regulated miR-106b inhibits ox-LDL-induced endothelial cell apoptosis in atherosclerosis. Braz J Med Biol Res. 2020;53(3):e8960.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–90.CrossRefPubMed Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–90.CrossRefPubMed
9.
Zurück zum Zitat Hsiao KY, Sun HS, Tsai SJ. Circular RNA - new member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–41.CrossRefPubMed Hsiao KY, Sun HS, Tsai SJ. Circular RNA - new member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 2017;242(11):1136–41.CrossRefPubMed
10.
Zurück zum Zitat Zhang F, Zhang R, Zhang X, Wu Y, Li X, Zhang S, et al. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits. Aging (Albany NY). 2018;10(9):2266–83.CrossRefPubMed Zhang F, Zhang R, Zhang X, Wu Y, Li X, Zhang S, et al. Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits. Aging (Albany NY). 2018;10(9):2266–83.CrossRefPubMed
11.
Zurück zum Zitat Altesha MA, Ni T, Khan A, Liu K, Zheng X. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234(5):5588–600.CrossRefPubMed Altesha MA, Ni T, Khan A, Liu K, Zheng X. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234(5):5588–600.CrossRefPubMed
12.
Zurück zum Zitat Cao Q, Guo Z, Du S, Ling H, Song C. Circular RNAs in the pathogenesis of atherosclerosis. Life Sci. 2020;255:117837.CrossRefPubMed Cao Q, Guo Z, Du S, Ling H, Song C. Circular RNAs in the pathogenesis of atherosclerosis. Life Sci. 2020;255:117837.CrossRefPubMed
13.
Zurück zum Zitat Wei Z, Ran H, Yang C. CircRSF1 contributes to endothelial cell growth, migration and tube formation under ox-LDL stress through regulating miR-758/CCND2 axis. Life Sci. 2020;259:118241.CrossRefPubMed Wei Z, Ran H, Yang C. CircRSF1 contributes to endothelial cell growth, migration and tube formation under ox-LDL stress through regulating miR-758/CCND2 axis. Life Sci. 2020;259:118241.CrossRefPubMed
14.
Zurück zum Zitat Wang G, Li Y, Liu Z, Ma X, Li M, Lu Q, et al. Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p. Mol Cell Biochem. 2020;471(1–2):51–61.CrossRefPubMed Wang G, Li Y, Liu Z, Ma X, Li M, Lu Q, et al. Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p. Mol Cell Biochem. 2020;471(1–2):51–61.CrossRefPubMed
15.
Zurück zum Zitat Li CY, Ma L, Yu B. Circular RNA hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis. Biomed Pharmacother. 2017;95:1514–9.CrossRefPubMed Li CY, Ma L, Yu B. Circular RNA hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis. Biomed Pharmacother. 2017;95:1514–9.CrossRefPubMed
16.
17.
Zurück zum Zitat Su Q, Sun Y, Ye Z, Yang H, Kong B, Li L. Pinocembrin protects endothelial cells from oxidized LDL-induced injury. Cytokine. 2018;111:475–80.CrossRefPubMed Su Q, Sun Y, Ye Z, Yang H, Kong B, Li L. Pinocembrin protects endothelial cells from oxidized LDL-induced injury. Cytokine. 2018;111:475–80.CrossRefPubMed
18.
Zurück zum Zitat Shang L, Quan A, Sun H, Xu Y, Sun G, Cao P. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575. Gene. 2019;711:143948.CrossRefPubMed Shang L, Quan A, Sun H, Xu Y, Sun G, Cao P. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from Apoe deficient mice through restricting circular RNA 0003575. Gene. 2019;711:143948.CrossRefPubMed
19.
Zurück zum Zitat Hu J, Wang L, Guan C. MiR-532-5p suppresses migration and invasion of lung cancer cells through inhibiting CCR4. Cancer Biother Radiopharm. 2020;35(9):673–81.PubMed Hu J, Wang L, Guan C. MiR-532-5p suppresses migration and invasion of lung cancer cells through inhibiting CCR4. Cancer Biother Radiopharm. 2020;35(9):673–81.PubMed
20.
Zurück zum Zitat Wei H, Tang QL, Zhang K, Sun JJ, Ding RF. MiR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2018;22(18):5842–50.PubMed Wei H, Tang QL, Zhang K, Sun JJ, Ding RF. MiR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer. Eur Rev Med Pharmacol Sci. 2018;22(18):5842–50.PubMed
21.
Zurück zum Zitat Ma J, Zhang J, Wang Y, Long K, Wang X, Jin L, et al. MiR-532–5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4. Gene. 2018;675:36–43.CrossRefPubMed Ma J, Zhang J, Wang Y, Long K, Wang X, Jin L, et al. MiR-532–5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4. Gene. 2018;675:36–43.CrossRefPubMed
22.
Zurück zum Zitat Yao Q, Zhu B. Effects of miR-532–5p on human brain microvascular endothelial cells damage induced by ox-LDL via down-regulating CLIC4 expression. Pak J Pharm Sci. 2020;33(3(Special)):1435–41.PubMed Yao Q, Zhu B. Effects of miR-532–5p on human brain microvascular endothelial cells damage induced by ox-LDL via down-regulating CLIC4 expression. Pak J Pharm Sci. 2020;33(3(Special)):1435–41.PubMed
23.
Zurück zum Zitat Sun H, Wu S, Sun B. MicroRNA-532-5p protects against atherosclerosis through inhibiting vascular smooth muscle cell proliferation and migration. Cardiovasc Diagn Ther. 2020;10(3):481–9.CrossRefPubMedPubMedCentral Sun H, Wu S, Sun B. MicroRNA-532-5p protects against atherosclerosis through inhibiting vascular smooth muscle cell proliferation and migration. Cardiovasc Diagn Ther. 2020;10(3):481–9.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Takeda Y, Matoba K, Kawanami D, Nagai Y, Akamine T, Ishizawa S, et al. ROCK2 Regulates monocyte migration and cell to cell adhesion in vascular endothelial cells. Int J Mol Sci. 2019;20(6):1331.CrossRefPubMedPubMedCentral Takeda Y, Matoba K, Kawanami D, Nagai Y, Akamine T, Ishizawa S, et al. ROCK2 Regulates monocyte migration and cell to cell adhesion in vascular endothelial cells. Int J Mol Sci. 2019;20(6):1331.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Sawada N, Liao JK. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal. 2014;20(8):1251–67.CrossRefPubMedPubMedCentral Sawada N, Liao JK. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal. 2014;20(8):1251–67.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci. 2007;28(6):296–302.CrossRefPubMed Shimokawa H, Rashid M. Development of Rho-kinase inhibitors for cardiovascular medicine. Trends Pharmacol Sci. 2007;28(6):296–302.CrossRefPubMed
27.
Zurück zum Zitat Huang L, Dai F, Tang L, Bao X, Liu Z, Huang C, et al. Distinct roles For ROCK1 and ROCK2 in the regulation of oxLDL-mediated endothelial dysfunction. Cell Physiol Biochem. 2018;49(2):565–77.CrossRefPubMed Huang L, Dai F, Tang L, Bao X, Liu Z, Huang C, et al. Distinct roles For ROCK1 and ROCK2 in the regulation of oxLDL-mediated endothelial dysfunction. Cell Physiol Biochem. 2018;49(2):565–77.CrossRefPubMed
28.
Zurück zum Zitat Shan H, Guo D, Zhang S, Qi H, Liu S, Du Y, et al. SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis. Cell Biosci. 2020;10:4.CrossRefPubMedPubMedCentral Shan H, Guo D, Zhang S, Qi H, Liu S, Du Y, et al. SNHG6 modulates oxidized low-density lipoprotein-induced endothelial cells injury through miR-135a-5p/ROCK in atherosclerosis. Cell Biosci. 2020;10:4.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Miao J, Wang B, Shao R, Wang Y. CircUSP36 knockdown alleviates oxidized lowdensity lipoproteininduced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR20a5p/ROCK2 axis. Int J Mol Med. 2021;47(4):40. Miao J, Wang B, Shao R, Wang Y. CircUSP36 knockdown alleviates oxidized lowdensity lipoproteininduced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR20a5p/ROCK2 axis. Int J Mol Med. 2021;47(4):40.
Metadaten
Titel
CircCHMP5 Contributes to Ox-LDL-induced Endothelial Cell Injury Through the Regulation of MiR-532-5p/ROCK2 axis
verfasst von
Xia Li
Xiaoli Kang
Yali Di
Shuxian Sun
Liming Yang
Bin Wang
Zheng Ji
Publikationsdatum
27.01.2022
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 6/2023
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-022-07316-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Koronare Herzkrankheit: Das waren die Top-Studien in 2024

Zum Thema Koronare Herzkrankheit gab es 2024 wichtige neue Studien. Beleuchtet wurden darin unter anderem der Stellenwert von Betablockern nach Herzinfarkt, neue Optionen für eine Lipidsenkung sowie die Therapie bei infarktbedingtem kardiogenem Schock.

Kaffeegenuss sicher bei Vorhofflimmern

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Mit jedem Defibrillationsversuch sinkt die Überlebenschance

Wie wirkt es sich auf die Prognose aus, wenn bei Herzstillstand einmal, zweimal oder gar 29 Mal geschockt werden muss? Laut einer aktuellen Studie besteht ein deutlicher Zusammenhang zwischen der Zahl der Defibrillationsversuche und den Überlebenschancen.

Mit Spenderherz von Triathlon zu Triathlon

Ein 50-Jähriger mit Spenderherz rennt, radelt und schwimmt bis zu 14 Stunden in der Woche – beim Hawaii-Triathlon erreicht er einen Platz im Mittelfeld. Sein neues Herz kann sich an die Belastung erstaunlich gut anpassen. Selbst mit 65 Jahren ist er noch ungewöhnlich fit.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.